Active pharmaceutical
ingredients (APIs) are defined as the chemicals utilized to create
pharmaceutical drugs. The active ingredients (AIs) are the biologically active
substances within the drug and are the particular components accountable for
the preferred effect they have on an individual having it. The Active
Pharmaceutical Ingredients (API) market is said to reach USD 239.8 billion by
2025 with a healthy CAGR of over 6 % during the forecast period (from 2014 to
2025). The increasing occurrence levels of various diseases such as cancer,
neurological diseases, cardiovascular diseases, and so on are some the major
factors expected to drive the growth of the global industry in the near future.
New Technologies:
The continuous-flow technology
includes the constant introduction of a stream of various chemical reactants
into microreactor or a flow to give in a wanted reaction product on a constant
basis. This technology can provide various potential benefits as compared to
the traditional batch production of pharmaceuticals, for example, superior
control & optimization of the process, an improved environmental profile
& safety for a given process, and a lowered manufacturing footprint as
compared to the batch reactor systems.
New Facility by Lonza Group:
The growing interest in
microreactor technology for fine-chemical manufacturing, Lonza Group has
invested in a new facility that will offer the creation of APIs and multiton
intermediates based on the continuous-flow technology. At present, the company
is operating the assets that can manufacture some kilograms to some tons of
small-molecule APIs with the help of microreactors. This new facility can offer
an incorporated solution where all the common unit functions in flow can be
managed in a flexible manner with microreactors—FlowPlate by Lonza.
Market Insights:
The global active
pharmaceutical ingredients (APIs) market is expected to
witness lucrative growth over the next few years. The growing advancements in
the recombinant molecular technologies and extensive capitalization for the
development of new drugs are also likely to propel the market growth. The key
players in the Active Pharmaceutical Ingredients (API) market are Teva
Pharmaceutical Industries Ltd.; AbbVie, Inc.; and Cipla, Inc. New
collaborations, acquisitions, regional expansions, and molecule launches are
some of the key strategies followed by all these market players in order to
maintain a stable position and market share.
In-Depth research report on active pharmaceutical
ingredients (APIs) market:
No comments:
Post a Comment